A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer

NCT06340165 · clinicaltrials.gov ↗
UNKNOWN
Status
153
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The First Hospital of Jilin University